Indication for anticoagulation therapy in these 6 patients were history of venous thrombotic events in 3 patients, antithrombin-III deficiency and factor V leiden-mutations in 1 patient each, prosthetic heart-valves in 2 patients, atrial fibrillation in 3 patients. The gene discussed is SERPINC1; the disease is atrial fibrillation.